The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Overview on biomarkers for immune oncology drugs”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Helen C. Steel, Theresa M. Rossouw, Ronald Anderson, Lindsay Anderson, Daniel van Tonder, Teresa Smit, Bernardo Leon Rapoport. Immunopathogenesis and Therapeutic Implications in Basal Cell Carcinoma: Current Concepts and Future Directions, Medicina. 2025; 61: 1914. https://doi.org/10.3390/medicina61111914 |
|
2 |
2025 |
Robert B. Kargbo, Tricyclic and Novel Chemotypes as Selective WRN Helicase Inhibitors for MSI-H Cancer Therapy, ACS Medicinal Chemistry Letters. 2025; 16: 1721. https://doi.org/10.1021/acsmedchemlett.5c00474 |
|
3 |
2026 |
Tiia Snäkä, Alex Friedlaender, Michele Graciotti, Miriam Hernandez, Laetitia Rossier, Volker Kirchner, Lana Kandalaft. Personalized cancer vaccines and their integration with standard of care modalities, Cancer Treatment Reviews. 2026; 143: 103095103095. https://doi.org/10.1016/j.ctrv.2026.103095 |
|
4 |
2025 |
Robert B. Kargbo, Targeting Werner Syndrome Helicase with Small Molecules in Mismatch Repair-Deficient Cancers, ACS Medicinal Chemistry Letters. 2025; 16: 945. https://doi.org/10.1021/acsmedchemlett.5c00262 |